The role of human papilloma virus and herpes viruses in the etiology of nasal polyposis

The role of human papilloma virus and herpes viruses in the etiology of nasal polyposis

Backround/aim: The aim of this study was to investigate the etiological role of human papilloma virus (HPV), herpes simplex virus (HSV), varicella-zoster virus (VZV), Epstein Barr virus (EBV), cytomegalovirus (CMV), and human herpes virus-6 (HHV-6) and -7 (HHV-7) in the occurrence of nasal polyposis. Materials and methods: Nasal polyp samples from 30 patients with nasal polyposis and normal nasal mucosa from 10 patients without nasal polyps were obtained. DNA was extracted from tissues. Real-time polymerase chain reaction was performed for all runs. Results: No HSV-1, HSV-2, or VZV was detected in the samples. Among the patient samples, EBV and HHV-7 DNA were detected in 18 (60%), HHV-6 was detected in 20 (66.7%), and HPV was detected in 4 (13.3%) samples. Among the controls, CMV DNA was positive in one (10%). EBV was positive in 5 (50%), HHV-6 and HHV-7 were positive in 7 (70%), and HPV was positive in 2 (20%) samples. No significant difference was found among the groups with any test in terms of positivity. Conclusion: The association of Herpesviridae and HPV with the pathogenesis of nasal polyps was investigated in this study and no relationship was found. Thus, these viruses do not play a significant role in the formation of nasal polyps.

___

  • 1. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthm R 2005; 5: 463–471.
  • 2. Kitapçi F, Muluk NB, Atasoy P, Koç C. Nasal polyps. Van Tip Derg 2005; 12: 212–222.
  • 3. Bernstein JM, Kansal R. Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis. Curr Opin Otolaryngol 2005; 13: 39–44.
  • 4. Becker SS. Surgical management of polyps in the treatment of nasal airway obstruction. Otolaryng Clin N Am 2009; 42: 377–385.
  • 5. Aouad RK, Chiu AG. State of the art treatment of nasal polyposis. Am J Rhinol Allergy 2011; 25: 291–298.
  • 6. Zollner U, Schwarz TF. Diseases caused by human papilloma viruses (HPV). Dtsch Med Wochenschr 2011; 136: 1067–1072 (in German with abstract in English).
  • 7. Efstathiou S, Minson AC. Herpes virus-based vectors. Brit Med Bull 1995; 51: 45–55.
  • 8. Zaravinos A, Bizakis J, Spandidos DA. Prevalence of human papilloma virus and human herpes virus types 1–7 in human nasal polyposis. J Med Virol 2009; 81: 1613–1619.
  • 9. Gao PF, Chen WX, Xiao LY, Yan XJ. Detection of Epstein– Barr virus and human papillomavirus in sinonasal malignant neoplasms. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2000; 14: 347–348 (in Chinese with abstract in English).
  • 10. Kulkarni AA, Badve SV, Tapiawala SN, Deshpande RB, Shah BV. Cytomegalovirus nasal polyp after renal transplant. J Assoc Physician I 2003; 51: 614–615.
  • 11. Fokkens W, Lund V, Bachert C, Clement P, Hellings P, Holmstrom M, Jones N, Kalogjera L, Kennedy D, Kowalski M et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005; 60: 583–601.
  • 12. Johansson L, Akerlund A, Holmberg K, Melén I, Stierna P, Bende M. Evaluation of methods for endoscopic staging of nasal polyposis. Acta Otolaryngol 2000; 120: 72–76.
  • 13. Sham CL, To KF, Chan PK, Lee DL, Tong MC, van Hasselt CA. Prevalence of human papillomavirus, Epstein–Barr virus, p21, and p53 expression in sinonasal inverted papilloma, nasal polyp, and hypertrophied turbinate in Hong Kong patients. Head Neck 2012; 34: 520–533.
  • 14. Wang X, Zhang N, Glorieux S, Holtappels G, Vaneechoutte M, Krysko O, Zhang L, Han D, Nauwynck HJ, Bachert C. Herpes simplex virus type 1 infection facilitates invasion of Staphylococcus aureus into the nasal mucosa and nasal polyp tissue. PLoS One 2012; 7:e39875.
  • 15. Akintola-Ogunremi O, Luo Q, He TC, Wang HL. Is cytomegalovirus associated with human colorectal tumorigenesis? Am J Clin Pathol 2005; 123: 244–249.
  • 16. Tao Q, Srivastava G, Dickens P, Ho FCS. Detection of Epstein– Barr virus-infected mucosal lymphocytes in nasal polyps. Am J Pathol 1996; 4: 1111–1118.
  • 17. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Lymphocytes and non-lymphoid cells in human nasal polyps. J Allergy Clin Immunol 1991; 87: 470–475.
  • 18. Buchwald C, Norrild B. Human papillomavirus in sinonasal papillomas and in normal nasal mucosa. Papillomavirus Report 1997; 8: 99–104.
  • 19. Hoffmann M, Kahn T, Goeroegh T, Lohrey C, Gottschlich S, Meyer J, Rudert H, Maune S. Tracing human papillomavirus DNA in nasal polyps by polymerase chain reaction. Acta Otolaryngol 2000; 120: 872–875.
  • 20. Hoffmann M, Klose N, Gottschlich S, Görögh T, Fazel A, Lohrey C, Rittgen W, Ambrosch P, Schwarz E, Kahn T. Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms. Cancer Lett 2006; 239: 64–70.
  • 21. Sun P, Chen XP, Pei F, Ma RX, Zhang Y, Chen Q, Dong WG, Chen WX, Huang HL. Relationship between nasal inverted papilloma and human papillomavirus subtypes. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010; 45: 310–313 (in Chinese with abstract in English).
  • 22. Ogura H, Fukushima K, Watanabe S. A high prevalence of human papillomavirus DNA in recurrent nasal papillomas. J Med Microbiol 1996; 45: 162–166.
  • 23. Pei F, Chen XP, Zhang Y, Wang Y, Chen Q, Tan XJ, Zhang JF, Xue XC, Wu J, Qing ZR. Human papillomavirus infection in nasal polyps in a Chinese population. Gen Virol 2011; 92: 1795–1799.
  • 24. Jing D, Yong-Chang X, Xin-Bo W. Expression of human papillomavirus DNA in nasal polyp. Chinese J Otorhinolar 2003; 4: 220–222.
  • 25. Zhou Y, Hu M, Liu C. Human papillomavirus DNA test in nasal polypsis. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2001; 15: 212–213 (in Chinese with abstract in English).
  • 26. Casale M, Pappacena M, Potena M, Vesperini E, Ciglia G, Mladina R, Dianzani C, Degener AM, Salvinelli F. Nasal polyposis: from pathogenesis to treatment, an update. Inflamm Allergy Drug Targets 2011; 10: 158–163.